Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

101.

Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma.

N. Engl. J. Med.
Sullivan RJ, Lawrence DP, Wargo JA, Oh KS, Gonzalez RG, Piris A.
| Jul 11, 2013
102.

Gene patenting--the Supreme Court finally speaks.

N. Engl. J. Med.
Kesselheim AS, Cook-Deegan RM, Winickoff DE, Mello MM.
| Aug 29, 2013
103.

Clinical problem-solving. A patient with migrating polyarthralgias.

N. Engl. J. Med.
Casey JD, Solomon DH, Gaziano TA, Miller AL, Loscalzo J.
| Jul 4, 2013
104.

Mental health and the global agenda.

N. Engl. J. Med.
Becker AE, Kleinman A.
| Jul 4, 2013
107.

Case records of the Massachusetts General Hospital. Case 18-2013: a 32-year-old woman with recurrent episodes of altered consciousness.

N. Engl. J. Med.
Cole AJ, Eskandar E, Mela T, Noebels JL, Gonzalez RG, McGuone D.
| Jun 13, 2013
108.

Clinical problem-solving. Waiting for the other foot to drop.

N. Engl. J. Med.
Scully EP, Klompas M, Morgan EA, Miller AL, Loscalzo J.
| Jun 6, 2013
109.

Central precocious puberty caused by mutations in the imprinted gene MKRN3.

N. Engl. J. Med.
Abreu AP, Dauber A, Macedo DB, Noel SD, Brito VN, Gill JC, Cukier P, Thompson IR, Navarro VM, Gagliardi PC, Rodrigues T, Kochi C, Longui CA, Beckers D, de Zegher F, Montenegro LR, Mendonca BB, Carroll RS, Hirschhorn JN, Latronico AC, Kaiser UB.
| Jun 27, 2013
110.

Acquired resistance to crizotinib from a mutation in CD74-ROS1.

N. Engl. J. Med.
Awad MM, Katayama R, McTigue M, Liu W, Deng YL, Brooun A, Friboulet L, Huang D, Falk MD, Timofeevski S, Wilner KD, Lockerman EL, Khan TM, Mahmood S, Gainor JF, Digumarthy SR, Stone JR, Mino-Kenudson M, Christensen JG, Iafrate AJ, Engelman JA, Shaw AT.
| Jun 20, 2013
111.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

N. Engl. J. Med.
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Jänne PA.
| Jun 20, 2013
115.

MUC5B promoter polymorphism and interstitial lung abnormalities.

N. Engl. J. Med.
Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, Nishino M, Araki T, Zazueta OE, Kurugol S, Ross JC, San José Estépar R, Murphy E, Steele MP, Loyd JE, Schwarz MI, Fingerlin TE, Rosas IO, Washko GR, O'Connor GT, Schwartz DA.
| Jun 6, 2013
117.

Perspectives of physicians and nurse practitioners on primary care practice.

N. Engl. J. Med.
Donelan K, DesRoches CM, Dittus RS, Buerhaus P.
| May 16, 2013
118.

Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding.

N. Engl. J. Med.
Penson RT, Goodman A, Growdon WB, Borger DR, Lee SI, Oliva E.
| May 9, 2013
119.

Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination.

N. Engl. J. Med.
Margolin DH, Kousi M, Chan YM, Lim ET, Schmahmann JD, Hadjivassiliou M, Hall JE, Adam I, Dwyer A, Plummer L, Aldrin SV, O'Rourke J, Kirby A, Lage K, Milunsky A, Milunsky JM, Chan J, Hedley-Whyte ET, Daly MJ, Katsanis N, Seminara SB.
| May 23, 2013
120.

Clinical problem-solving. In the thick of it.

N. Engl. J. Med.
Rao DA, Lakdawala NK, Miller AL, Loscalzo J.
| May 2, 2013